Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Flebogamma

 
National Institutes of Health

Related topics

Related topics

4 relations
200 ML Immunoglobulin G, Human 50 MG/ML Injection [Flebogamma]50 ML Immunoglobulin G, Human 50 MG/ML Injection [Flebogamma]

Broader (2)

Immunoglobulin GImmunoglobulin G, Human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Evaluation of the Efficacy and Safety of Griflow® Dual, a Pre-Set Two-Flow Infusion Device for Intravenous Immunoglobulin (Flebogamma® 5%) Administration
Purpose A single center, prospective study was performed to assess the efficacy and safety of Griflow® Dual–-a gravity-fed device… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
2009
2009
Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy
  • J. Jorquera
  • Clinical and experimental immunology
  • 2009
    • Corpus ID: 45309116
Flebogamma® 5% dual inactivation and filtration (DIF), a new 5% liquid intravenous immunoglobulin with a stability of 2 years… Expand
2009
2009
Clinical experience with Flebogamma® 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease
  • M. Ballow
  • Clinical and experimental immunology
  • 2009
    • Corpus ID: 26342233
The development of effective, safe, liquid intravenous immunoglobulins (IVIG) preparations has represented a major therapeutic… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE